Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 11 studies | 28% ± 11% | |
peripheral blood | 10 studies | 22% ± 5% | |
kidney | 6 studies | 19% ± 3% | |
brain | 6 studies | 29% ± 3% | |
liver | 5 studies | 28% ± 17% | |
intestine | 5 studies | 23% ± 11% | |
bone marrow | 3 studies | 19% ± 2% | |
prostate | 3 studies | 22% ± 5% | |
lymph node | 3 studies | 21% ± 1% | |
breast | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1630.42 | 1445 / 1445 | 100% | 41.68 | 183 / 183 |
lung | 100% | 2387.05 | 578 / 578 | 100% | 45.79 | 1155 / 1155 |
pancreas | 100% | 1622.33 | 328 / 328 | 100% | 41.86 | 178 / 178 |
prostate | 100% | 2129.02 | 245 / 245 | 100% | 64.65 | 502 / 502 |
brain | 100% | 2324.88 | 2641 / 2642 | 100% | 47.09 | 705 / 705 |
thymus | 100% | 2283.40 | 653 / 653 | 100% | 49.97 | 604 / 605 |
intestine | 100% | 2086.00 | 966 / 966 | 100% | 51.70 | 526 / 527 |
bladder | 100% | 1768.33 | 21 / 21 | 100% | 45.60 | 503 / 504 |
uterus | 100% | 1945.71 | 170 / 170 | 100% | 44.95 | 458 / 459 |
ovary | 100% | 2113.26 | 180 / 180 | 100% | 39.99 | 429 / 430 |
kidney | 100% | 1991.96 | 89 / 89 | 100% | 31.98 | 898 / 901 |
stomach | 100% | 1890.99 | 359 / 359 | 100% | 46.73 | 285 / 286 |
breast | 100% | 2253.86 | 459 / 459 | 99% | 45.78 | 1110 / 1118 |
skin | 100% | 1871.19 | 1809 / 1809 | 99% | 36.31 | 468 / 472 |
adrenal gland | 100% | 2304.71 | 258 / 258 | 97% | 25.06 | 224 / 230 |
liver | 100% | 791.64 | 226 / 226 | 72% | 11.35 | 291 / 406 |
adipose | 100% | 2144.12 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 77.98 | 29 / 29 |
spleen | 100% | 2730.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 33.19 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.96 | 1 / 1 |
blood vessel | 100% | 1612.84 | 1331 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2945.01 | 919 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 1060.78 | 849 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 719.12 | 780 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 24.25 | 75 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015031 | Biological process | protein transport |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0016020 | Cellular component | membrane |
GO_0012505 | Cellular component | endomembrane system |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | SFT2D1 |
Protein name | SFT2D1 protein Vesicle transport protein SFT2A (SFT2 domain-containing protein 1) (pRGR1) |
Synonyms | C6orf83 |
Description | FUNCTION: May be involved in fusion of retrograde transport vesicles derived from an endocytic compartment with the Golgi complex. . |
Accessions | ENST00000361731.4 Q4G178 Q8WV19 |